# =

11b-hydroxylase inhibitor

# .

Metyrapone treats Cushing syndrome.

Metyrapone tests hypothalamus-pituitary-adrenal axis.

Intact axis increases corticotrophin-releasing hormone, adrenocorticotropic hormone, and glucocorticoid precursors.

Axis with impaired hypothalamus or pituitary gland fails to increase adrenocorticotropic hormone.

Axis with adrenal insufficiency increases corticotrophin-releasing hormone and adrenocorticotropic hormone but not the precursors.

# <

# >

Hypocortisolemia
